| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $915.8M | -41.9% |
| Cost of Revenue | $618.1M | -46.8% |
| Gross Profit | $297.7M | -28.4% |
| R&D Expense | $6.7M | -21.2% |
| SG&A Expense | $160.6M | +0.6% |
| Operating Income | -$227.0M | -206.0% |
| Pre-tax Income | -$250.6M | -241.4% |
| Income Tax | -$10.2M | -125.5% |
| Net Income | -$240.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $363.0M | +45.7% |
| Accounts Receivable | $275.8M | -17.0% |
| Inventory | $200.8M | +24.0% |
| Current Assets | $998.7M | +20.0% |
| Total Assets | $1.43B | -16.4% |
| Current Liabilities | $437.8M | +30.4% |
| Long-term Debt | $646.6M | -2.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $154.0M | -33.6% |
| Capital Expenditures | $7.3M | -57.0% |
| Investing Cash Flow | -$9.6M | +43.1% |
| Financing Cash Flow | -$11.8M | +88.4% |
| Free Cash Flow | $146.7M | -31.8% |
| -275.2% |
| EPS (Basic) | -$1.95 | -442.1% |
| EPS (Diluted) | -$1.95 | -448.2% |
| Total Liabilities |
| $1.14B |
| +3.7% |
| Stockholders' Equity | -$118.1M | -145.6% |